# Molecule

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/molecule

- Industry: Financial Services
- Headquarters: Switzerland
- Website: www.molecule.to
- Total disclosed funding: $13M
- Latest round: Seed (Jun 13, 2022)
- Investors on record: 4

## About

In 2019, the company was co-founded by Paul Kohlhaas, a serial entrepreneur and web3 engineer, and Tyler Golato, a biomedical researcher. Throughout 2020 to 2022, the company has raised over 13 million from investors including Backed VC, Shine Capital, Speedinvest and former Coinbase CTO Balaji Srinivasan. As of 2022, the company has reached partnership with a Newcastle University study into molecular aging and a University of Copenhagen project into longevity.

The company operates as decentralized science (DeSci) platform for medical research firm. The company's solution can make research get funded through crowdfunding via decentralised autonomous organizations (DAOs) and also decentralise it in terms of ownership. The research project will be turned into NFTs to signal intellectual property (IP).

## Funding rounds

- Seed, Jun 13, 2022, $13M — Speedinvest, Backed VC, Northpond Ventures, Shine Capital

## Investors

- Speedinvest (https://capitalatlas.ai/funds/speedinvest) — Seed
- Backed VC (https://capitalatlas.ai/funds/backed-vc) — Seed
- Northpond Ventures (https://capitalatlas.ai/funds/northpond-ventures) — Seed
- Shine Capital — Seed